Isolator Qualification and Smoke Studies for Aseptic Processing

Three transfer mechanisms cover most of what an isolator actually needs to move across its boundary, and each one solves the problem a different way.

B1.1  Rapid transfer ports (RTPs)

Practice An RTP is a docking system built around two matched half-ports — commonly described as an "alpha" door, permanently mounted on a transfer container, and a "beta" door mounted on the isolator wall. When the two are docked and locked together, they open as a single unit, so the two doors' inner faces effectively become one continuous surface facing into the isolator, and the container's contents can be removed without room air, or the container's own exterior, ever contacting the isolator's interior. Undocking reverses the process, resealing both doors independently. Because the transfer container itself can be decontaminated separately — often in its own VHP chamber — before it is ever docked, RTPs are the standard mechanism for bringing sterilized components (stoppers, syringes, subassemblies) into an aseptic isolator without opening the isolator itself to room air at any point.

B1.2  Pass-throughs and mouseholes

Practice A pass-through is a small chamber with two interlocked doors — one facing the isolator's interior, one facing the room — that never open simultaneously. Placing an item inside from the room side, closing that door, and only then opening the isolator-side door (often after its own short VHP or UV decontamination cycle inside the chamber) allows small items to cross without ever creating a direct, simultaneous opening between room air and the critical zone. A "mousehole" transfer is the same basic interlock principle applied to continuous or semi-continuous flow — commonly used for moving already-processed, stoppered vials out of the critical zone toward capping or inspection, where the item leaving is no longer as vulnerable as an open container would be.

B1.3  Continuous liners

Practice For waste and for some component supply, a continuous liner — a long sealed plastic sleeve threaded through a port and heat-sealed or clamped at intervals — lets material cross the boundary continuously without ever creating an open pathway back into the isolator, since each sealed segment is separated from the next before the port is ever exposed to room air on the outside.

---

B2.1  The pressure decay method

Practice The standard physical test inflates the sealed volume between a test cap and the glove's inner surface to a target pressure — commonly in the range of 500–1,000 Pa — and then monitors that pressure over a fixed observation period. A drop in pressure indicates a leak somewhere in the glove material or at the securing point where the glove attaches to the isolator wall or an RTP sleeve.

Practice This method reliably and reproducibly detects a calibrated hole on the order of 100 µm. A single bacterial spore is on the order of 1 µm — two orders of magnitude smaller — and testing at that resolution is not currently practical: pushing the method's sensitivity that far sharply increases both false positives and result-to-result variability. The gap between what the test can reliably catch and the size of what it is ultimately trying to keep out is worth sitting with. Pressure decay testing is a real, validated control, not a formality — but it is not proof that no pathway smaller than roughly 100 µm exists, and a facility's overall contamination control strategy has to account for that residual gap rather than treat a passing glove test as a complete answer.

B2.2  How often, and why that number is convention, not regulation

Practice Common industry practice is to run a physical integrity test on every glove immediately before each production batch, supplemented by a visual inspection for obvious damage before the test even begins. Neither FDA's guidance nor Annex 1 writes "test before every batch" into the text as a fixed numeric requirement — what both documents require is that the facility's contamination control strategy demonstrate glove integrity is adequately assured, and pre-batch testing is simply the way the industry has converged on doing that. A facility could, in principle, justify a different frequency through its own risk assessment and historical data — but in practice, almost nobody does, because pre-batch testing is inexpensive relative to the cost of an undetected breach reaching product.

---

B3.1  The four phases of a VHP cycle

Practice A vaporized hydrogen peroxide (VHP) bio-decontamination cycle is typically run in four phases:

• Dehumidification — the isolator's internal humidity is reduced, commonly to a target in the region of 5–40% relative humidity, to establish consistent starting conditions. This step is sometimes skipped where the following phase is designed to rely on micro-condensation instead.
• Conditioning — environmental parameters are brought to the specific values the decontamination phase requires before the active agent is introduced.
• Bio-decontamination — vaporized hydrogen peroxide is introduced and held, with commonly cited target values on the order of 600–1,000 ppm H₂O₂ at 50–100% relative humidity, for a validated dwell time. This is the phase that actually has to deliver the required microbial log reduction to every interior surface, including surfaces shadowed by fixtures or equipment — a cycle validated only against exposed, easy-to-reach surfaces has not actually validated the isolator as a whole.
• Aeration — residual hydrogen peroxide is broken down, typically passed through a catalytic converter that reduces it to water vapor and oxygen, until residual levels fall to a level safe for personnel and for the product about to be introduced.

B3.2  Biological indicators, and the organism doing the work

Requirement The only tool capable of directly demonstrating an actual spore log reduction is a biological indicator (BI) — a carrier inoculated with a known, high population of a resistant organism, placed at defined locations (including deliberately difficult, shadowed locations) throughout the isolator during a qualification cycle, then recovered and cultured to determine whether, and how completely, the population was killed.

Practice Geobacillus stearothermophilus is the organism almost universally used for VHP qualification. Two ATCC strains are both in common use — ATCC #12980 and ATCC #7953 — and they are not interchangeable: ATCC #12980 has been observed to be measurably more resistant to the VHP process than ATCC #7953. A cycle validated against the less resistant strain has not necessarily proven the same margin against the more resistant one, which is why the specific BI strain used in a qualification study is a detail worth checking, not assuming.

B3.3  How many logs is actually enough? A real disagreement worth knowing about

Practice Cycle validation itself is typically demonstrated across three consecutive successful qualification runs, each meeting the chosen log-reduction acceptance criterion at every BI location — a single successful run is treated as anecdote, not proof of a repeatable process.

---

B4.1  The pressure cascade, and the number Arc A promised

Requirement The pressure cascade is the deliberate arrangement of positive pressure differentials between adjacent areas of different classification, engineered so that air always flows from the more classified (cleaner) space toward the less classified one — never the reverse. FDA's commonly cited minimum expectation for the differential between adjacent rooms of different classification is 0.04–0.06 inches of water gauge (10–15 Pascals). This figure recurs across multiple FDA warning letters discussing cascade failures — including Arc A's Brassica Pharma case, where readings fell below the site's own established range and, at times, went negative, meaning air could flow the wrong direction, from a lower-classified space into the critical zone, rather than only ever the reverse.

Practice A pressure cascade is not simply "more pressure is better." Too great a differential between adjacent doors can itself create turbulence or make doors difficult to operate safely; the goal is a controlled, monitored, continuously maintained differential within a validated range — not the largest number an HVAC system can produce.

B4.2  IQ, OQ, PQ — applied specifically to an isolator

Practice The standard three-stage qualification framework applies to isolators the same way it applies to any other piece of qualified equipment, but each stage has isolator-specific content:

• Installation Qualification (IQ) — confirms the isolator, its transfer systems, HEPA filtration, and instrumentation are installed as specified and per the approved design, with calibration records for every critical instrument (pressure sensors, H₂O₂ sensors, particle counters) on file before any testing proceeds.
• Operational Qualification (OQ) — demonstrates the isolator performs as intended across its full operating range under controlled, non-production conditions: HEPA integrity (typically a DOP/PAO challenge test), pressure cascade performance across the full range of door/RTP operations, and, centrally, VHP decontamination cycle qualification as covered in Module B3.
• Performance Qualification (PQ) — demonstrates the isolator performs as intended under actual or fully representative operating conditions, including personnel present and performing the interventions that occur in real production. This is where Arc C's smoke studies, and Arc E's aseptic process simulations (media fills), actually sit within the qualification lifecycle — they are PQ evidence, not a separate, freestanding activity bolted on afterward.